Here's what to expect this week on Diagnostic Imaging.
In this week’s preview, here are some highlights of what you can expect to see coming soon:
The Society for Imaging Informatics in Medicine is holding its 2021 Virtual Annual meeting this week. Look for our ongoing coverage of research and educational sessions from the conference.
For more SIIM 2021 Virtual Annual Meeting coverage, click here.
For more coverage based on industry expert insights and research, subscribe to the Diagnostic Imaging e-Newsletter here.
COVID-19 has changed the way the industry has leveraged consumer technologies. From smartphones to gaming video cards to QR codes, Paul Shumway, vice president from Novarad, offers insights on the possibilities present with existing technologies.
For technology coverage, click here.
Women do not always mention breast pain or complications to their primary care provider or gynecologist first. In many instances, these women end up in the emergency department. However, that setting isn’t necessarily the best equipped for evaluating the breast. In an article published in the Journal of Breast Imaging, investigators analyze the outcomes experienced when women seek care in an emergency environment. Look for our coverage this week.
For other content on breast imaging and emergency care, click here.
GE HealthCare Launches AI Mammography Platform with Key Applications from iCAD
November 30th 2023Offering an all-in-one platform of artificial intelligence (AI) applications, MyBreastAI Suite reportedly facilitates early breast cancer detection and enhances efficiency with breast imaging workflows.
FDA Clears Magnetic Resonance Spectroscopy Platform for Non-Invasive Assessment of Brain Chemistry
November 29th 2023BrainSpec Core reportedly offers enhanced sensitivity for low-grade gliomas and may facilitate the diagnosis of conditions including Alzheimer’s disease, multiple sclerosis, and epilepsy.
Study Says Contrast-Enhanced Mammography Offers Comparable Breast Cancer Detection to MRI
November 15th 2023In findings from an enriched cohort of asymptomatic patients with screening-detected abnormalities, researchers found that contrast-enhanced mammography (CEM) was superior to conventional mammography and offered equivalent detection of breast cancer in comparison to breast MRI and abbreviated breast MRI.